|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Feb―27 |
COVID-19-Associated Myocardial Injury |
David M. Kaye, Hitesh C. Patel |
2 |
[GO] |
2022―Oct―19 |
Myocardial Injury and Altered Gene Expression Associated With SARS-CoV-2 Infection or mRNA Vaccination |
Natasha L. Altman, Amber A. Berning, Cara E. Saxon, Kylie E. Adamek, Jessica A. Wagner, Dobromir Slavov, et al. (+14) Robert A. Quaife, Edward A. Gill, Wayne A. Minobe, Eric R. Jonas, Ian A. Carroll, Sophia P. Huebler, Joshua Raines, John C. Messenger, Amrut V. Ambardekar, Luisa Mestroni, Rachel M. Rosenberg, Jessica Rove, Thomas B. Campbell, Michael R. Bristow |
3 |
[GO] |
2022―Sep―14 |
Human Cardiac Pericytes are Susceptible to SARS-CoV-2 Infection |
Brittany D. Brumback, Oleksandr Dmytrenko, Ashley N. Robinson, Adam L. Bailey, Pan Ma, Jing Liu, et al. (+9) Stephanie C. Hicks, Sherwin Ng, Gang Li, David M. Zhang, Catherine E. Lipovsky, Chieh-Yu Lin, Michael S. Diamond, Kory Lavine, Stacey L. Rentschler |
4 |
[GO] |
2022―May―23 |
Proteomic Analyses Unveil Actionable Disease Pathways in COVID-19 |
George Vasquez-Rios, Girish N. Nadkarni |
5 |
[GO] |
2022―May―04 |
Plasma Proteomics of COVID-19-Associated Cardiovascular Complications |
Jason D. Roh, Robert R. Kitchen, J. Sawalla Guseh, Jenna N. McNeill, Malika Aid, Amanda J. Martinot, et al. (+17) Andy Yu, Colin Platt, James Rhee, Brittany Weber, Lena E. Trager, Margaret H. Hastings, Sarah Ducat, Peng Xia, Claire Castro, Abhilasha Singh, Bjarni Atlason, Timothy W. Churchill, Marcelo F. Di Carli, Patrick T. Ellinor, Dan H. Barouch, Jennifer E. Ho, Anthony Rosenzweig |
6 |
[GO] |
2022―Mar―28 |
The Erythrocyte, a Novel Disease-Mediator for COVID-19 Vasculopathy? |
Carlo Brugnara |
7 |
[GO] |
2022―Feb―16 |
Erythrocytes Induce Vascular Dysfunction in COVID-19 |
Ali Mahdi, Aida Collado, John Tengbom, Tong Jiao, Tigist Wodaje, Niclas Johansson, et al. (+6) Filip Farnebo, Anna Färnert, Jiangning Yang, Jon O. Lundberg, Zhichao Zhou, John Pernow |
8 |
[GO] |
2022―Feb―09 |
The Pathogenesis and Long-Term Consequences of COVID-19 Cardiac Injury |
Bhurint Siripanthong, Babken Asatryan, Thomas C. Hanff, Salman R. Chatha, Mohammed Y. Khanji, Fabrizio Ricci, et al. (+8) Daniele Muser, Victor A. Ferrari, Saman Nazarian, Pasquale Santangeli, Rajat Deo, Leslie T. Cooper, Saidi A. Mohiddin, C. Anwar A. Chahal |
9 |
[GO] |
2022―Jan―24 |
HIF-1α Cardioprotection in COVID-19 Patients |
Bingyan J. Wang, Sangeetha Vadakke-Madathil, Lori B. Croft, Rachel I. Brody, Hina W. Chaudhry |
10 |
[GO] |
2021―Dec―08 |
Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19 |
Thorsten M. Leucker, William O. Osburn, Paula Reventun, Kimberley Smith, Brian Claggett, Bridget-Anne Kirwan, et al. (+7) Sophie de Brouwer, Marlene S. Williams, Gary Gerstenblith, David N. Hager, Michael B. Streiff, Scott D. Solomon, Charles J. Lowenstein |
11 |
[GO] |
2021―Sep―29 |
In the Ongoing Conflict Between Ideology and Immunity, Which Side Will Protect the Children From Post-Acute Sequelae of COVID-19? |
Amanda K. Verma, Douglas L. Mann |
12 |
[GO] |
2021―Sep―15 |
Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection |
David H. Jiang, Darius J. Roy, Brett J. Gu, Leslie C. Hassett, Rozalina G. McCoy |
13 |
[GO] |
2021―Apr―27 |
The Essential Vulnerability of Human Cardiac Myocytes to SARS-CoV-2 |
Mitali Das, Michael R. Bristow, Mina K. Chung |
14 |
[GO] |
2021―Feb―26 |
SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis |
Adam L. Bailey, Oleksandr Dmytrenko, Lina Greenberg, Andrea L. Bredemeyer, Pan Ma, Jing Liu, et al. (+23) Vinay Penna, Emma S. Winkler, Sanja Sviben, Erin Brooks, Ajith P. Nair, Kent A. Heck, Aniket S. Rali, Leo Simpson, Mehrdad Saririan, Dan Hobohm, W. Tom Stump, James A. Fitzpatrick, Xuping Xie, Xianwen Zhang, Pei-Yong Shi, J. Travis Hinson, Weng-Tein Gi, Constanze Schmidt, Florian Leuschner, Chieh-Yu Lin, Michael S. Diamond, Michael J. Greenberg, Kory J. Lavine |
15 |
[GO] |
2021―Feb―26 |
What Are the Clinical Implications of the SARS-CoV-2 Variants |
Adriana M. Rauseo, Jane A. O’Halloran |
16 |
[GO] |
2021―Feb―24 |
Platelet and Endothelial Activation as Potential Mechanisms Behind the Thrombotic Complications of COVID-19 Patients |
Paola Canzano, Marta Brambilla, Benedetta Porro, Nicola Cosentino, Elena Tortorici, Stefano Vicini, et al. (+13) Paolo Poggio, Andrea Cascella, Martino F. Pengo, Fabrizio Veglia, Susanna Fiorelli, Alice Bonomi, Viviana Cavalca, Daniela Trabattoni, Daniele Andreini, Emanuela Omodeo Salè, Gianfranco Parati, Elena Tremoli, Marina Camera |
17 |
[GO] |
2021―Jan―10 |
Now That We Have an Effective Vaccine for COVID-19, Will It Also Inoculate Us Against the Virus of Indifference? |
Douglas L. Mann |
18 |
[GO] |
2020―Dec―28 |
Will COVID-19 Transform Translational Medicine? |
Douglas L. Mann |
19 |
[GO] |
2020―Nov―23 |
RNA Vaccines for COVID-19: Five Things Every Cardiologist Should Know |
Chien-Jung Lin, Robert P. Mecham, Douglas L. Mann |
20 |
[GO] |
2020―Oct―23 |
In the Age of CoVID: Genomic Changes Over the Lifespan Help Explain Severe SARS-CoV-2 Disease |
Brandon J. Beddingfield, Gregory J. Bix |
21 |
[GO] |
2020―Oct―16 |
The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection |
Brandon J. Beddingfield, Naoki Iwanaga, Prem P. Chapagain, Wenshu Zheng, Chad J. Roy, Tony Y. Hu, et al. (+2) Jay K. Kolls, Gregory J. Bix |
22 |
[GO] |
2020―Oct―09 |
Cardiorenal tissues express SARS-CoV-2 entry genes and basigin (BSG/CD147) increases with age in endothelial cells |
Blerina Ahmetaj-Shala, Ricky Vaja, Santosh S. Atanur, Peter M. George, Nicholas S. Kirkby, Jane A. Mitchell |
23 |
[GO] |
2020―Sep―22 |
MULTIORGAN DAMAGE IN PATIENTS WITH COVID-19: IS THE TGF-β /BMP PATHWAY THE MISSING LINK? |
F. Roy Carlson, Dattatreyamurty Bosukonda, Peter C. Keck, William D. Carlson |
24 |
[GO] |
2020―Jul―25 |
COVID-19 and the Heart: ACE2 Level is Not Destiny, But the Company It Keeps May Hold the Fate |
Han-Bin Lin, Peter P. Liu |
25 |
[GO] |
2020―Jun―26 |
Warped Speed: How COVID-19 Transfected and Transformed Medical Journals |
Douglas L. Mann |
26 |
[GO] |
2020―Jun―24 |
Dynamic Regulation of SARS-CoV-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular Myocardium |
Michael R. Bristow, Lawrence S. Zisman, Natasha L. Altman, Edward M. Gilbert, Brian D. Lowes, Wayne A. Minobe, et al. (+7) Dobromir Slavov, Jessica A. Schwisow, Erin M. Rodriguez, Ian A. Carroll, Thomas A. Keuer, Peter M. Buttrick, David P. Kao |
27 |
[GO] |
2020―Jun―17 |
“Warp Speed” Operations in the COVID-19 Pandemic: Moving Too Quickly? |
Gail A. Van Norman |
28 |
[GO] |
2020―May―26 |
The National Institute of Allergy and Infectious Diseases Decision to Stop the Adaptive COVID-19 Treatment Trial (ACCT-1): On Solid Ethical and Scientific Ground |
Jessica Mozersky, Douglas L. Mann, James M. DuBois |
29 |
[GO] |
2020―Apr―28 |
SARS-CoV-2 and Bats: From Flight to Fighting COVID-19 |
Douglas L. Mann |
30 |
[GO] |
2020―Apr―18 |
Precision medicine in COVID-19: IL-1β a potential target |
Valentina Parisi, Dario Leosco |
31 |
[GO] |
2020―Apr―16 |
COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities |
Bonnie Ky, Douglas L. Mann |
32 |
[GO] |
2020―Apr―10 |
COVID-19 for the Cardiologist: A Current Review of the Virology, Clinical Epidemiology, Cardiac and Other Clinical Manifestations and Potential Therapeutic Strategies |
Deepak Atri, Hasan K. Siddiqi, Joshua Lang, Victor Nauffal, David A. Morrow, Erin A. Bohula |
33 |
[GO] |
2020―Mar―25 |
Chinese Health Care Workers and COVID-19: For Whom the Bell Tolls |
Douglas L. Mann |